Document is current
Any future updates will be listed below
-
Authors
Karp, Simone
Trautmann-Grill, Karolin
Warncke, Paul
Zolnowski, Dominik
Röllig, Christoph
Pannach, Marcel
Zinn, Jessica
Kroschinsky, Frank
Morgner, Anke
von Bonin, Malte
Hänel, Annette
Herbst, Regina
Fricke, Stephan
Bornhäuser, Martin
Hänel, Mathias https://orcid.org/0000-0002-4767-3275
Teipel, Raphael https://orcid.org/0000-0002-9985-6583
-
Funding
Funding for this research was provided by:
Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
- License Information
-
More Information
Article History
Received: 7 June 2024
Accepted: 13 February 2025
First Online: 26 February 2025
Declarations
:
: The study was approved by the regional ethics committees of the State Chamber of Physicians of Saxony (EK-BR-40/23 − 1).
: Patient consent was waived in accordance with the ethical approval due to retrospective design of the analysis and anonymization.
: K. Trautmann-Grill has received consultation fees and/or honoraria from Sanofi, Takeda, Novartis, Amgen, GSK, Janssen; travel grants from Janssen, NovoNordisk, GSK, Sanofi and has participated in Data Safety Monitoring Board or advisory boards for Sanofi, Novartis, Amgen, GSK. M. Hänel has received consultations fees and/or honoraria from Novartis, Amgen, GSK, Celgene, Sanofi-Aventis, Janssen, and Bristol-Myers Squibb. R. Herbst has received honoraria from Novartis, Bristol-Myers Squibb and Amgen. R. Teipel has participated in advisory boards or has received honoraria from Janssen, Bristol-Myers Squibb, Takeda, GSK, Gilead, Sanofi, Amgen, Stemline, Oncopeptides and Abbvie as well as research and travel grants from Janssen. All other authors declare no competing financial interests in relation to the work described. All authors declare that potential competing interests did not influence the content and results of the manuscript.
